Embed this press release by copying the code below:
NASDAQ: ACRS Shareholder Notice: Deadline on September 30, 2019 in Lawsuit Against Aclaris Therapeutics, Inc.
NASDAQ: ACRS Shareholder Notice: Deadline on September 30, 2019 in Lawsuit Against Aclaris Therapeutics, Inc.